STAT

My decade leading the WHO: dirty fights and steps toward universal coverage

Dr. Margaret Chan looks back at her 10-year tenure as director-general of the World Health Organization. She steps down from that post on June 30, 2017.
Departing WHO Director-General Margaret Chan

As a young doctor working in Hong Kong’s department of maternal and child health, I learned some lessons that would last me a lifetime. Trained by the British civil service, I absorbed the importance of discipline and a methodical approach to every task. But I always ran behind schedule in my appointments with patients because I spent time trying to find the root causes of illnesses that came as much from social circumstances as from microbes. I could cure a child with a severe respiratory illness, but when that child went home to a damp and moldy house, I knew I would see her again with the same illness.

In 1994, when I became the director of Hong Kong’s department of health, I learned the lesson that it is wise to do whatever it takes to get government

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks